Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Zelle General Manager, Denise Leonard, joins Cheddar to discuss how the company had record breaking 2024 with billions of dollars in transactions. Watch!
Verb Founder Rory Cutaia discusses how Market.Live will change how small businesses reach new audiences and talks the latest season of Go Fund Yourself. Watch!